SB801

Pharmaceutical companies; creating the Oklahoma Medicine Injury Justice Act; providing for civil and criminal liability. Effective date. Emergency.

Introduced·2/3/25
Int Text

Oklahoma SB801 establishes the Oklahoma Medicine Injury Justice Act, holding pharmaceutical companies liable for damages caused by their products in.

Oklahoma SB801, known as the Oklahoma Medicine Injury Justice Act, ensures that pharmaceutical companies are held liable for harm caused by their products in Oklahoma state courts. The act guarantees due process for Oklahoma citizens harmed by pharmaceutical products and prohibits arbitration or other limitations on access to justice. It defines "fraud" and "gross negligence" and specifies that federal immunity statutes do not apply to claims brought in Oklahoma state courts.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Judiciary Committee
Next
Committee decision

Sponsors

0
1
R
Democratic CaucusRepublican Caucus

History

Feb 4, 2025

Senate

Second Reading referred to Judiciary

Feb 3, 2025

Senate

First Reading

Feb 3, 2025

Senate

Authored by Senator Deevers